“Hemophagocytic Lymphohistiocytosis after EBV reactivation and ibrutinib treatment in relapsed/refractory Chronic Lymphocytic Leukemia”

Hemophagocytic Lymphohistiocytosis (HLH) is a rare syndrome characterized by ineffective T-cell and NK response. We report the clinical course of a patient with relapsed CLL who developed acute symptoms soon after starting ibrutinib. Hyperpyrexia, splenomegaly, hyperferritinemia, hypertriglyceridemi...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Leuk Res Rep
Prif Awduron: Cavallari, Maurizio, Ciccone, Maria, Falzoni, Simonetta, Cavazzini, Francesco, Formigaro, Luca, Di Virgilio, Francesco, Rotola, Antonella, Rigolin, Gian Matteo, Cuneo, Antonio
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Elsevier 2017
Pynciau:
Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC5288319/
https://ncbi.nlm.nih.gov/pubmed/28180067
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.lrr.2017.01.002
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg